Benefits
May support modest weight loss alongside diet and exercise
In an eight-week trial of 23 overweight adults following a diet and exercise program, 100 mg twice daily was linked to about 2.9 kg of weight loss versus 1 kg on placebo. A second eight-week trial of a formula containing it found a gap of about 1.4 kg, but two further trials found no weight difference. The effect, if real, is small.
Helps maintain resting metabolic rate during calorie restriction
Dieting normally lowers resting energy use. In a one-week crossover trial in 40 overweight dieters, resting metabolic rate fell 3.9% on placebo but rose 1.4% on 7-keto DHEA, a gap of roughly 100 kcal a day. Weight over that week did not differ from placebo, and blood sugar did not change in the trials that checked it.
Fat-burning claims outrun the trial data
Only one of four trials found a drop in body fat percentage and only one found a lower BMI. Three were led by the same investigator, three included multi-ingredient formulas, and the two trials with extra weight loss appeared in journal issues PubMed does not index. An independent review of all four said no clear answer can be given.
Did not raise testosterone or estrogen in an oral safety trial
In an escalating-dose trial in 22 healthy men ending with 200 mg a day for four weeks, testosterone, free testosterone, DHT, estradiol, cortisol, thyroxine and insulin stayed in the normal range with no lab differences from placebo. Isotope testing shows it is not turned back into DHEA. Women were not studied, and skin application did shift hormones in men.
Prohibited for athletes under anti-doping rules
WADA lists 7-keto DHEA among anabolic androgenic steroids banned in and out of competition. Because the body makes small amounts naturally, anti-doping labs rely on specialized methods to detect supplement use, and chemists warn its breakdown products can complicate how results are read. Any athlete subject to testing should avoid it.
Mechanism of action
Thermogenic liver enzymes in rats
Fed to rats, 7-oxo-DHEA induced two liver enzymes that complete a heat-producing cycle, mitochondrial sn-glycerol-3-phosphate dehydrogenase and cytosolic malic enzyme, and did so more strongly than DHEA itself. This animal finding is the original basis for the fat-burning claim.
Energy released as heat rather than ATP
The proposed pathway resembles thyroid hormone: the glycerophosphate shuttle bypasses part of the respiratory chain, so more fuel and oxygen are burned for the same ATP and the surplus escapes as heat. Reviewers present this as a hypothesis built on animal work, not a measured effect in people.
Competition with tissue cortisol regeneration
The enzyme 11-beta-HSD1 turns inactive cortisone into cortisol inside tissues and also interconverts 7-oxygenated DHEA metabolites. In human skin preparations 7-oxo-DHEA inhibited cortisone reduction, hinting at a local anti-cortisol role. Whether oral doses change tissue cortisol in people is untested.
Rapid conversion to a sulfate with a short half-life
The acetyl ester taken by mouth was not detectable in blood; it was converted to 7-oxo-DHEA sulfate, which peaked about 2.2 hours after a dose, had a half-life near 2.2 hours and did not build up over four weeks. That fits the twice-daily dosing used in the weight trials.
Little conversion to sex hormones
Early researchers held that 7-oxo steroids cannot become testosterone or estrogen, and isotope-ratio testing after a single human dose found no DHEA formed from 7-keto DHEA. In one cell study, though, 7-oxo-DHEA activated estrogen receptor beta, partly via aromatase, and spurred breast cancer cell growth.
Clinical trials
Systematic review of placebo-controlled clinical trials of 7-keto DHEA for weight loss, searched across bibliographic databases and two trial registers (Jeyaprakash N, Maeder S, Janka H, Stute P 2023, Arch Gynecol Obstet 308(3):777-785, PMID 36566478).
Four randomized double-blind trials, all from the United States, with 131 overweight or obese adults aged 20 to 70, mostly women, treated for one to eight weeks with 102 to 200 mg a day.
Two of four trials reported more weight loss than placebo over eight weeks (2.88 vs 0.97 kg and 2.15 vs 0.72 kg); one reported lower body fat percentage, one a lower BMI, and two a higher resting metabolic rate. No serious adverse effects were reported. Three trials shared a lead author and three included a multi-ingredient formula. The reviewers concluded that no clear answer can be given regarding weight loss and that more studies are needed before any therapeutic use.
Randomized, double-blind, placebo-controlled crossover trial of 3-acetyl-7-oxo-DHEA alone and within the HUM5007 formula (Zenk JL, Frestedt JL, Kuskowski MA 2007, J Nutr Biochem 18(9):629-34, PMID 17418559).
45 overweight adults on a calorie-restricted diet (40 completed; 30 women, 10 men; mean BMI 32), each taking 7-keto DHEA, HUM5007 and placebo for 7 days in random order with 7-day washouts.
Resting metabolic rate fell 3.9% (75 kcal/day) during placebo but rose 1.4% (21 kcal/day) on 7-keto DHEA and 3.4% (59 kcal/day) on HUM5007, each P=.001 versus placebo. Compliance and adverse events did not differ. Each period lasted only a week, and the independent review reports that weight change did not differ from placebo.
Randomized, double-blind, placebo-controlled trial of a commercial weight-loss product that the 2023 review lists as supplying 102 mg/day of 7-keto DHEA among other ingredients (Zenk JL, Leikam SA, Kassen LJ, Kuskowski MA 2005, Nutrition 21(2):179-85, PMID 15723746).
47 healthy overweight adults (35 completed) on a calorie-restricted diet and moderate exercise program for 8 weeks.
Resting metabolic rate rose 7.2% on the product versus a 0.7% fall on placebo (P=0.03), and hip circumference fell more (3.78 vs 2.07 cm). No other outcome differed, including body weight, BMI, waist and DXA body composition. Because the product is a multi-ingredient formula, the result cannot be credited to 7-keto DHEA alone.
Randomized, double-blind, placebo-controlled escalating-dose study of oral 3-acetyl-7-oxo-DHEA (Davidson M, Marwah A, Sawchuk RJ, Maki K, Marwah P, Weeks C, Lardy H 2000, Clin Invest Med 23(5):300-10, PMID 11055323).
22 healthy men (16 active, 6 placebo) given 50 mg/day for 7 days, 100 mg/day for 7 days and 200 mg/day for 28 days, with 7-day washouts between the first steps.
Laboratory values, vital signs and reported minor adverse events did not differ from placebo, and testosterone, free testosterone, DHT, estradiol, cortisol, thyroxine and insulin stayed in the normal range. The ester was converted to 7-oxo-DHEA sulfate (peak 2.2 h, half-life 2.17 h) without accumulation. The study covered men only, and its senior author also led the early rat research on the compound.